Recently, the mixed-lineage leukemia (MLL) protein complex, more commonly implicated as a driver of MLL fusion-positive leukemias, was also shown to interact with AR signaling in advanced PCa, demonstrating the increasing complexity of characterizing transcriptional drivers of PCa [12]. This evidence concerns the gene KMT2A and leukemia.